Camp4 Therapeutics Corporation/$CAMP
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Camp4 Therapeutics Corporation
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
- Ticker
- $CAMP
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 48
- Headquarters
- Cambridge, United States
- Website
- www.camp4tx.com
CAMP Metrics
BasicAdvanced
$233M
-
-$2.18
-
-
Price and volume
Market cap
$233M
52-week high
$7.75
52-week low
$2.90
Average daily volume
231K
Financial strength
Current ratio
4.703
Quick ratio
4.525
Long term debt to equity
-2.266
Total debt to equity
-3.423
Profitability
EBITDA (TTM)
-50.561
Gross margin (TTM)
-817.69%
Net profit margin (TTM)
-2,543.74%
Operating margin (TTM)
-1,242.50%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-45.25%
Return on equity (TTM)
-545.85%
Valuation
Price to revenue (TTM)
43.471
Price to book
-278.76
Price to tangible book (TTM)
-278.76
Price to free cash flow (TTM)
-6.381
Free cash flow yield (TTM)
-15.67%
Free cash flow per share (TTM)
-0.583
Growth
Revenue change (TTM)
40.21%
Earnings per share change (TTM)
-38.92%
What the Analysts think about CAMP
Analyst ratings (Buy, Hold, Sell) for Camp4 Therapeutics Corporation stock.
Analyst projections of the future price of Camp4 Therapeutics Corporation stock.
CAMP Financial Performance
Revenues and expenses
CAMP Earnings Performance
Company profitability
Upcoming events
No upcoming events
CAMP News
AllArticlesVideos
Funds containing CAMP
Fund name | Fund size | $CAMP weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.00% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.